BACKGROUND AND OBJECTIVES: Cardiac abnormalities were frequently noted in patients with chronic kidney disease (CKD). This study is designed to assess whether echocardiographic parameters are associated with rate of renal function decline and progression to dialysis in CKD stage 3 to 5 patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This longitudinal study enrolled 415 patients. The renal end point was defined as commencement of dialysis. The change in renal function was measured by estimated GFR (eGFR) slope. RESULTS: Progression to dialysis was predicted by wide pulse pressure, low albumin, low hemoglobin, high calcium-phosphorous product, proteinuria, diuretics use, and concentric left ventricular hypertrophy (LVH) (hazard ratio, 2.03; 95% confidence interval [CI], 1.00 to 4.10; P = 0.05). The eGFR slope was negatively associated with total cholesterol, uric acid, proteinuria, diuretics use, and left atrial (LA) diameter (change in slope, -0.50; 95% CI, -0.89 to -0.11; P = 0.01) and positively associated with albumin and left ventricular ejection fraction (LVEF) (change in slope, 0.06; 95% CI, 0.03 to 0.08; P < 0.001). CONCLUSIONS: Our study in patients of CKD stage 3 to 5 demonstrated that concentric LVH was associated with progression to dialysis, and that increased LA diameter and decreased LVEF were associated with faster renal function decline. Echocardiography may help identify high-risk groups with progressive decline in renal function to dialysis and rapid progression of renal dysfunction in CKD stage 3 to 5 patients.
BACKGROUND AND OBJECTIVES:Cardiac abnormalities were frequently noted in patients with chronic kidney disease (CKD). This study is designed to assess whether echocardiographic parameters are associated with rate of renal function decline and progression to dialysis in CKD stage 3 to 5 patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This longitudinal study enrolled 415 patients. The renal end point was defined as commencement of dialysis. The change in renal function was measured by estimated GFR (eGFR) slope. RESULTS: Progression to dialysis was predicted by wide pulse pressure, low albumin, low hemoglobin, high calcium-phosphorous product, proteinuria, diuretics use, and concentric left ventricular hypertrophy (LVH) (hazard ratio, 2.03; 95% confidence interval [CI], 1.00 to 4.10; P = 0.05). The eGFR slope was negatively associated with total cholesterol, uric acid, proteinuria, diuretics use, and left atrial (LA) diameter (change in slope, -0.50; 95% CI, -0.89 to -0.11; P = 0.01) and positively associated with albumin and left ventricular ejection fraction (LVEF) (change in slope, 0.06; 95% CI, 0.03 to 0.08; P < 0.001). CONCLUSIONS: Our study in patients of CKD stage 3 to 5 demonstrated that concentric LVH was associated with progression to dialysis, and that increased LA diameter and decreased LVEF were associated with faster renal function decline. Echocardiography may help identify high-risk groups with progressive decline in renal function to dialysis and rapid progression of renal dysfunction in CKD stage 3 to 5 patients.
Authors: P Palatini; P Visentin; P Mormino; M Pietra; D Piccolo; E Cozzutti; V Mione; P Bocca; F Perissinotto; A C Pessina Journal: Am J Cardiol Date: 1998-02-15 Impact factor: 2.778
Authors: G de Simone; R B Devereux; T R Kimball; G F Mureddu; M J Roman; F Contaldo; S R Daniels Journal: Hypertension Date: 1998-05 Impact factor: 10.190
Authors: A Veves; C M Akbari; J Primavera; V M Donaghue; D Zacharoulis; J S Chrzan; U DeGirolami; F W LoGerfo; R Freeman Journal: Diabetes Date: 1998-03 Impact factor: 9.461
Authors: K Wachtell; G Smith; E Gerdts; B Dahlöf; M S Nieminen; V Papademetriou; J N Bella; H Ibsen; J Rokkedal; R B Devereux Journal: Am J Cardiol Date: 2000-02-15 Impact factor: 2.778
Authors: Leila R Zelnick; Ronit Katz; Bessie A Young; Adolfo Correa; Bryan R Kestenbaum; Ian H de Boer; Nisha Bansal Journal: Am J Kidney Dis Date: 2017-01-28 Impact factor: 8.860
Authors: Alexander Kainz; Georg Goliasch; Franz Wiesbauer; Thomas Binder; Gerald Maurer; Hans-Joachim Nesser; Regina Mascherbauer; Christian Ebner; Reinhard Kramar; Julia Wilflingseder; Rainer Oberbauer Journal: Clin J Am Soc Nephrol Date: 2013-09-05 Impact factor: 8.237
Authors: Yuhree Kim; Kunihiro Matsushita; Yingying Sang; Morgan E Grams; Hicham Skali; Amil M Shah; Ron C Hoogeveen; Scott D Solomon; Christie M Ballantyne; Josef Coresh Journal: Am J Kidney Dis Date: 2014-10-23 Impact factor: 8.860